Public
American Hospital Association content that is available to the public and all website users.
Statement over the CMS interim final rule on data collection and Medicare conditions of participation (CoPs) from AHA President and CEO Rick Pollack .
Please log in to the website to see the talking points on CMS’s Interim Final Rule on Data Collection and Medicare Conditions of Participation.
Sign In to Download the Regulatory Advisory:
Medicare Physician Fee Schedule: Proposed Rule for CY 2021
AHA comments on the Centers for Medicare & Medicaid Services’ calendar year 2021 proposed rule for the Home Health prospective payment system (PPS).
Researchers recently revealed an information about a vulnerability affecting the electronic chips that enable mobile communication in millions of internet connected devices.
For more than 25 years, the 340B program has enabled hospitals that care for many low-income and uninsured patients to purchase certain outpatient drugs from drug companies at discounted prices
AHA to Eli Lilly and Company Re: Actions to Collect Data to Limit Distribution of Certain 340B Drugs
AHA expresses profound concern about actions Eli Lilly and Company is taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and health systems.
AHA expresses profound concern about actions Sanofi U.S./Sanofi Genzyme are taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and health systems.
AHA expresses profound concern about actions AztraZeneca is taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and health systems.
AHA expresses profound concern about actions Novartis Corporation Global, is taking to collect data intended to limit the distribution of certain 340B drugs to hospitals and health systems.